Raghav, Kanwal Pratap Singh
Mayo Clinic
The University of Texas MD Anderson Cancer Center
Citations 1
MOUNTAINEER-03 phase III study design: first-line mFOLFOX6 + tucatinib + trastuzumab for HER2+ metastatic colorectal cancer
Bekaii‐Saab, Tanios , Cercek, Andrea , Heinemann, Volker , Raghav, Kanwal Pratap Singh, Yoshino, Takayuki, Ramos, Jorge , Guan, Xuesong, André, Thierry , Bekaii-Saab, Tanios S , Strickler, John H. , Nakamura, Yoshiaki, Siena, Salvatore , Tabernero, Josep , Cutsem, Eric Van , Yoshino, Takayuki , André, Thierry
Future Oncology | December 26, 2024 | Volume: 21 | Issue: 3 | Pages: 303-311
